• Resources
  • Blog
  • Journalists
  • Log In
  • Sign Up
  • Data Privacy
  • Send a Release
Cision PR Newswire: news distribution, targeting and monitoring home
  • News
  • Products
    • Overview
    • Distribution by PR Newswire
    • Cision Communications Cloud®
    • Cision IR
    • All Products
  • Contact
    • General Inquiries
    • Request a Demo
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices

 

When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases
      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview
      • Multimedia Gallery
      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview
      • Trending Topics
      • All Trending Topics
  • Business & Money
      • Auto & Transportation
      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview
      • Business Technology
      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview
      • Entertain­ment & Media
      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview
      • Financial Services & Investing
      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview
      • General Business
      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview
  • Science & Tech
      • Consumer Technology
      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview
      • Energy & Natural Resources
      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview
      • Environ­ment
      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview
      • Heavy Industry & Manufacturing
      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview
      • Telecomm­unications
      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview
  • Lifestyle & Health
      • Consumer Products & Retail
      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview
      • Entertain­ment & Media
      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview
      • Health
      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview
      • Sports
      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview
      • Travel
      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview
  • Policy & Public Interest
      • Policy & Public Interest
      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview
  • People & Culture
      • People & Culture
      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview
      • In-Language News

      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
    • Send a Release
    • Sign Up
    • Log In
    • Resources
    • Blog
    • Journalists
    • RSS
    • GDPR
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
    • Send a Release
    • Sign Up
    • Log In
    • Resources
    • Blog
    • Journalists
    • RSS
    • GDPR
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
    • Send a Release
    • Sign Up
    • Log In
    • Resources
    • Blog
    • Journalists
    • RSS
    • GDPR
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
    • Send a Release
    • Sign Up
    • Log In
    • Resources
    • Blog
    • Journalists
    • RSS
    • GDPR
  • Policy & Public Interest
    • Send a Release
    • Sign Up
    • Log In
    • Resources
    • Blog
    • Journalists
    • RSS
    • GDPR
  • People & Culture
    • People & Culture
    • Send a Release
    • Sign Up
    • Log In
    • Resources
    • Blog
    • Journalists
    • RSS
    • GDPR
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR

Kemin Industries e CBD Vida lançam Produtos Derivados de Cannabis para fins Medicinais para pacientes no Brasil
  • USA - English

Kemin Industries

News provided by

Kemin Industries

Apr 14, 2020, 09:00 ET

Share this article

Share this article


Os produtos da marca CBD CALM já estão disponíveis para compra on-line no Brasil

DES MOINES, Iowa, 14 de abril de 2020 /PRNewswire/ -- A Kemin Industries, atuando como consultora da MedPharm Iowa, fabricante e fornecedora de produtos derivados de Cannabis para fins medicinais que aspira sempre a melhora da qualidade de vida dos cidadãos do Estado de Iowa, EUA, e que buscam soluções médicas naturais e cientificamente comprovadas, e a CBD Vida Ltda, companhia brasileira pioneira no fornecimento de produtos derivados de Cannabis para fins exclusivamente medicinais, anunciou o lançamento de novos produtos derivados de Cannabis para fins medicinais, produzidos a partir da planta Cannabis sativa L.,  fabricados em conjunto com parceiros no Colorado e Michigan, sob a marca CBD CALM, no Brasil.

A Kemin Industries é uma fabricante global de ingredientes que se esforça em transformar de maneira sustentável a qualidade de vida diária de 80 porcento do mundo com seus produtos e serviços. Como consultora da MedPharm Iowa, a empresa formou uma parceria com a CBD Vida em março para distribuir produtos contendo derivados de cannabis para fins medicinais em padrões farmacêuticos no Brasil.

 "A Kemin está entusiasmada por atuar como consultora líder da MedPharm Iowa, uma organização confiável que fornece produtos derivados de Cannabis para fins medicinais de alta qualidade em dispensários licenciados no Estado de Iowa, EUA, para exportar para a CBD Vida no Brasil nosso conhecimento e experiência na área dos produtos derivados de Cannabis para fins medicinais", disse o Dr. Chris Nelson, Presidente e CEO da Kemin.

O Brasil alterou recentemente os seus regulamentos sobre produtos derivados de Cannabis para permitir que pacientes comprem produtos que contenham canabidiol, sob prescrição médica, diretamente das farmácias.

"Vemos os produtos derivados de Cannabis para fins medicinais como uma nova e empolgante oportunidade de transformar vidas, e com o nosso compromisso em trazer aos pacientes do Brasil produtos com a mesma qualidade que a MedPharm Iowa oferece aos seus clientes em Iowa, EUA", disse José Piccolotto, presidente da Kemin Human Nutrition and Health.

A Kemin e a CBD Vida estão trabalhando em parceria para assegurarem o cumprimento de todos os requisitos técnicos e documentais da Resolução RDC Nº 327 da Agência Nacional do Brasil (Anvisa), de 09 de dezembro de 2019. A CBD Vida planeja disponibilizar produtos derivados de Cannabis para fins medicinais em farmácias e drogarias brasileiras ainda este ano.

A parceria entre a Kemin Industries e a CBD Vida permite que os pacientes brasileiros tenham acesso ao CBD CALM de acordo com os novos critérios para importação de produtos derivados de Cannabis para fins medicinais para o Brasil, conforme definido na Resolução Brasileira RDC N° 335, de 24 de janeiro de 2020.

"Com o lançamento de nossos novos produtos CBD CALM, a CBD Vida continua comprometida em melhorar a vida dos pacientes e de suas famílias, oferecendo o apoio, a inovação e a qualidade que eles esperam encontrar ao trabalharem connosco", disse Fábio Candello, CEO da CBD Vida.

Os pacientes no Brasil agora podem comprar os produtos CBD CALM no site da CBD Vida, www.cbdvida.com.br.

Para saber mais sobre a Kemin Industries, com sede em Des Moines, Iowa, EUA, visite www.keminhemp.com.

Kemin Industries

Kemin Industries (www.kemin.com) é um fabricante global de ingredientes que se esforça em transformar de maneira sustentável a qualidade de vida diária a 80 porcento do mundo com seus produtos e serviços. A empresa fornece mais de 500 ingredientes especiais para a saúde e nutrição humana através de ingredientes funcionais e tecnologias alimentares, saúde e nutrição animal através de alimentos para animais de estimação, além de atuar na aquicultura, tecnologias agrícolas e indústrias têxteis.

Por mais de meio século, a Kemin se dedica ao uso da ciência aplicada para enfrentar os desafios do setor e oferecer soluções de produtos para clientes em mais de 120 países. A Kemin fornece ingredientes para uma população em crescimento com o firme compromisso de oferecer qualidade, segurança e eficácia em seus produtos.

Fundada em 1961, a Kemin é uma empresa privada, de propriedade e operação familiar, com mais de 2.800 funcionários e operações globais em 90 países, incluindo instalações de fabris na Bélgica, Brasil, China, Índia, Itália, Rússia, São Marinho, Singapura, África do Sul e Estados Unidos.

CBD Vida

A CBD Vida (www.cbdvida.com.br) é uma empresa brasileira, com sede administrativa e operacional em Campinas - São Paulo - Brasil. Fundada em 2016, a CBD Vida trabalha com o único objetivo de fornecer acesso aos melhores produtos derivados de Cannabis, para pacientes no Brasil, com um elevado padrão de qualidade e responsabilidade para com a nossa comunidade.

Contato media Kemin:
Miguel Martinho, Marketing Manager, [email protected], +351 214 157 500

Contato media CBD Vida:
Fábio Camata Candello, CEO, [email protected], +55 19 99769 3411

Certas declarações podem não ser aplicáveis em todas as regiões geográficas. A rotulagem do produto e as afirmações associadas podem diferir com base nos requisitos do governo e Agências de Saúde.

Logo - https://mma.prnewswire.com/media/901853/New_Kemin_Logo.jpg

FONTE Kemin Industries

Related Links

http://www.kemin.com

SOURCE Kemin Industries

Modal title

Also from this source

Kemin Industries Acquires Proteus Industries, Inc....

Kemin Industries Acquires Proteus Industries, Inc....


Kemin Becomes Majority Shareholder in Animal Vaccine Company...

Kemin Becomes Majority Shareholder in Animal Vaccine Company...

Explore

More news releases in similar topics

  • Agriculture
  • Cannabis
  • Supplementary Medicine
  • Health Care & Hospitals
  • Licensing

    Contact Cision

  • Cision Distribution 888-776-0942
    from 8 AM - 9 PM ET

  • Chat with an Expert
    • General Inquiries
    • Request a Demo
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices

    Products

  • Cision Communication Cloud®
  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • For Small Business
  • All Products

    About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • COVID-19 Resources
  • Accessibility Statement

    • Asia
    • Brazil
    • Canada
    • Czech
    • Denmark
    • Finland
    • France
    • Germany
    • India
    • Israel
    • Italy
    • Mexico
    • Middle East
    • Netherlands
    • Norway
    • Poland
    • Portugal
    • Russia
    • Slovakia
    • Spain
    • Sweden
    • United Kingdom

    My Services

  • All New Releases
  • Online Member Center
  • ProfNet

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2021 Cision US Inc.